Kurs
-1,97%
Kurs
-1,97%
Kalender
| Tid* | ||
| 2026-02-25 | N/A | Bokslutskommuniké 2025 |
| 2025-11-26 | N/A | Kvartalsrapport 2025-Q3 |
| 2025-08-20 | N/A | Kvartalsrapport 2025-Q2 |
| 2025-05-22 | N/A | Årsstämma |
| 2025-05-14 | N/A | Kvartalsrapport 2025-Q1 |
| 2025-02-26 | N/A | Bokslutskommuniké 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2024-05-16 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-16 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2023-05-11 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-23 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-16 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2022-05-12 | - | Årsstämma |
| 2022-03-31 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-21 | - | Bokslutskommuniké 2020 |
| 2020-11-17 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-07 | - | Split NYKD 1:5 |
| 2020-07-06 | - | Extra Bolagsstämma |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2021-09-10 17:06:21
Jan Haudemann-Andersen, member of the board of Vaccibody AS, owns directly or
indirectly Datum AS, Datum Invest AS, Datum Opportunity AS, Datum Vekst AS and
Datum Finans AS.
The Datum Group has today, September 10, 2021, reallocated its shareholdings in
Vaccibody AS:
Datum Invest AS has sold 5 000 000 shares at NOK 79 per share
Datum AS has sold 21 000 000 shares at NOK 79 per share
Datum Vekst AS has sold 2 395 500 shares at NOK 79 per share
Datum Opportunity AS has bought 26 000 000 shares at NOK 79 per share.
Datum Finans AS has bought 2 395 500 shares at NOK 79 per share.
Following the transactions, the companies' shareholdings are:
Datum Invest AS - no shares
Datum Vekst AS - no shares
Datum AS - 11 634 250 shares
Datum Opportunity - 26 000 000 shares
Datum Finans AS - 2 395 500 shares
Jan Haudemann-Andersen and the Datum Group hold an unchanged number of 40 263
050 shares in Vaccibody AS after the above transactions.
Please see further details in attached document.